Implantable cardioverter-defibrillator elective generator replacement: a procedure for all?

详细信息    查看全文

• 作者：Sergio Barra ; Manoj Goonewardene…
• 关键词：Implantable cardioverter ; defibrillator ; Generator replacement ; ICD therapy ; Risk stratification ; All ; cause mortality
• 刊名：Journal of Interventional Cardiac Electrophysiology
• 出版年：2016
• 出版时间：March 2016
• 年：2016
• 卷：45
• 期：2
• 页码：209-218
• 全文大小：552 KB
• 参考文献：1.The Antiarrhythmics Versus Implantable Defibrillators (AVID) Investigators. (1997). A comparison of antiarrhythmic drug therapy with implantable defibrillators in patients resuscitated from near-fatal ventricular arrhythmias. N Engl J Med, 337, 1576–1583.CrossRef
  2.Connolly, S. J., Gent, M., Roberts, R. S., Dorian, P., Roy, D., Sheldon, R. S., Mitchell, L. B., et al. (2000). Canadian implantable defibrillator study (CIDS): a randomized trial of the implantable cardioverter defibrillator against amiodarone. Circulation, 101(11), 1297–302.CrossRef PubMed
  3.Kuck, K. H., Cappato, R., Siebels, J., & Rüppel, R. (2000). Randomized comparison of antiarrhythmic drug therapy with implantable defibrillators in patients resuscitated from cardiac arrest: the Cardiac Arrest Study Hamburg (CASH). Circulation, 102(7), 748–54.CrossRef PubMed
  4.Moss, A. J., Hall, W. J., Cannom, D. S., Daubert, J. P., Higgins, S. L., Klein, H., Levine, J. H., et al. (1996). Improved survival with an implanted defibrillator in patients with coronary, disease at high risk for ventricular arrhythmia. Multicenter Automatic Defibrillator Implantation Trial Investigators. N Engl J Med, 335(26), 1933–40.CrossRef PubMed
  5.Moss, A. J., Zareba, W., Hall, W. J., Klein, H., Wilber, D. J., Cannom, D. S., Daubert, J. P., et al. (2002). Multicenter automatic defibrillator implantation trial II investigators. Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction. N Engl J Med, 346(12), 877–83. Epub 2002 Mar 19.CrossRef PubMed
  6.Kadish, A., Dyer, A., Daubert, J. P., Quigg, R., Estes, N. A., Anderson, K. P., Calkins, H., et al. (2004). Defibrillators in non-ischemic cardiomyopathy treatment evaluation (DEFINITE) investigators. Prophylactic defibrillator implantation in patients with nonischemic dilated cardiomyopathy. N Engl J Med, 350(21), 2151–8.CrossRef PubMed
  7.Bardy, G. H., Lee, K. L., Mark, D. B., Poole, J. E., Packer, D. L., Boineau, R., Domanski, M., et al. (2005). Sudden cardiac death in heart failure trial (SCD-HeFT) investigators. Amiodarone or an implantable cardioverter-defibrillator for congestive heart failure. N Engl J Med, 352, 225–237.CrossRef PubMed
  8.Bristow, M. R., Saxon, L. A., Boehmer, J., Krueger, S., Kass, D. A., De Marco, T., Carson, P., et al. (2004). Comparison of medical therapy, pacing, and defibrillation in heart failure (COMPANION) investigators. Cardiac-resynchronization therapy with or without an implantable defibrillator in advanced chronic heart failure. N Engl J Med, 350(21), 2140–50.CrossRef PubMed
  9.Gracieux, J., Sanders, G. D., Pokorney, S. D., Lopes, R. D., Thomas, K., & Al-Khatib, S. M. (2014). Incidence and predictors of appropriate therapies delivered by the implantable cardioverter defibrillator in patients with ischemic cardiomyopathy: a systematic review. Int J Cardiol, 177(3), 990–4.CrossRef PubMed
  10.Parkash, R., Stevenson, W. G., Epstein, L. M., & Maisel, W. H. (2006). Predicting early mortality after implantable defibrillator implantation: a clinical risk score for optimal patient selection. Am Heart J, 151(2), 397–403.CrossRef PubMed
  11.Goldenberg, I., Vyas, A. K., Hall, W. J., Moss, A. J., Wang, H., He, H., Zareba, W., MADIT-II Investigators, et al. (2008). Risk stratification for primary implantation of a cardioverter-defibrillator in patients with ischemic left ventricular dysfunction. J Am Coll Cardiol, 51(3), 288–96.CrossRef PubMed
  12.Bilchick, K. C., Stukenborg, G. J., Kamath, S., & Cheng, A. (2012). Prediction of mortality in clinical practice for medicare patients undergoing defibrillator implantation for primary prevention of sudden cardiac death. J Am Coll Cardiol, 60(17), 1647–55.PubMedCentral CrossRef PubMed
  13.Kraaier, K., Scholten, M. F., Tijssen, J. G., Theuns, D. A., Jordaens, L. J., & van Dessel, P. F. (2014). Early mortality in prophylactic implantable cardioverter-defibrillator recipients: development and validation of a clinical risk score. Europace, 16(1), 40–6.CrossRef PubMed
  14.Chung, M. K., Holcomb, R. G., Mittal, S., Steinberg, J. S., Gleva, M. J., Mela, T., Uslan, D. Z., Mitchell, K., Poole, J. E., & REPLACE Investigators. (2014). REPLACE DARE (death after replacement evaluation) score: determinants of all-cause mortality after implantable device replacement or upgrade from the REPLACE registry. Circ Arrhythm Electrophysiol, 7, 1048–1056.CrossRef PubMed
  15.Providencia, R., Boveda, S., Lambiase, P., Defaye, P., Algalarrondo, V., Sadoul, N., et al. (2015). Prediction of nonarrhythmic mortality in primary prevention implantable cardioverter-defibrillator patients with ischemic and nonischemic cardiomyopathy. JACCEP, 1(1), 29–37.
  16.Pencina, M. J., D'Agostino, R. B., Sr., D'Agostino, R. B., Jr., & Vasan, R. S. (2008). Evaluating the added predictive ability of a new marker: from area under the ROC curve to reclassification and beyond. Stat Med, 27(2), 157–172.CrossRef PubMed
  17.Van Welsenes, G. H., Van Rees, J. B., Thijssen, J., Trines, S. A., Van Erven, L., Schalij, M. J., & Borleffs, C. J. (2011). Primary prevention implantable cardioverter defibrillator recipients: the need for defibrillator back-up after an event-free first battery service-life. J Cardiovasc Electrophysiol, 22, 1346–1350.CrossRef PubMed
  18.Yap, S. C., Schaer, B. A., Bhagwandien, R. E., Kühne, M., Dabiri Abkenari, L., Osswald, S., Szili-Torok, T., et al. (2014). Evaluation of the need of elective implantable cardioverter-defibrillator generator replacement in primary prevention patients without prior appropriate ICD therapy. Heart, 100(15), 1188–92.CrossRef PubMed
  19.Kini, V., Soufi, M. K., Deo, R., Epstein, A. E., Bala, R., Riley, M., Groeneveld, P. W., et al. (2014). Appropriateness of primary prevention implantable cardioverter defibrillators at time of generator replacement: are indications still met? J Am Coll Cardiol, 63(22), 2388–94.CrossRef PubMed
  20.Erkapic, D., Sperzel, J., Stiller, S., Meltendorf, U., Mermi, J., Wegscheider, K., Hügl, B., INSURE Investigators, et al. (2013). Long-term benefit of implantable cardioverter/defibrillator therapy after elective device replacement: results of the INcidence free SUrvival after ICD REplacement (INSURE) trial--a prospective multicentre study. Eur Heart J, 34(2), 130–7.CrossRef PubMed
  21.Kramer DB, Kennedy KF, Spertus JA, Normand SL, Noseworthy PA, Buxton AE, Josephson ME et al. Mortality risk following replacement implantable cardioverter-defibrillator implantation at end of battery life: results from the NCDR®. Heart Rhythm. 2013.
  22.Alsheikh-Ali, A. A., Homer, M., Maddukuri, P. V., Kalsmith, B., Estes, N. A., 3rd, & Link, M. S. (2008). Time- dependence of appropriate implantable defibrillator therapy in patients with ischemic cardiomyopathy. J Cardiovasc Electrophysiol, 19(8), 784–9.CrossRef PubMed
  23.van Welsenes, G. H., van Rees, J. B., Borleffs, C. J., Cannegieter, S. C., Bax, J. J., van Erven, L., & Schalij, M. J. (2011). Long-term follow-up of primary and secondary prevention implantable cardioverter defibrillator patients. Europace, 13(3), 389–94.CrossRef PubMed
  24.Connolly, S. J., Hallstrom, A. P., Cappato, R., Schron, E. B., Kuck, K. H., Zipes, D. P., Greene, H. L., et al. (2000). Meta-analysis of the implantable cardioverter defibrillator secondary prevention trials. AVID, CASH and CIDS studies. Antiarrhythmics vs Implantable Defibrillator study. Cardiac Arrest Study Hamburg. Canadian Implantable Defibrillator Study. Eur Heart J, 21(24), 2071–8.CrossRef PubMed
  
• 作者单位：Sergio Barra (1)
  Manoj Goonewardene (1) (2)
  Patrick Heck (1)
  David Begley (1)
  Munmohan Virdee (1)
  Simon Fynn (1)
  Andrew Grace (1)
  Sharad Agarwal (1)
  
  1. Cardiology Department, Papworth Hospital NHS Foundation Trust, Papworth Everard, Cambridge, CB23 3RE, UK
  2. Cardiology Department, Hinchingbrooke Hospital, Huntingdon, Cambridgeshire, PE29 6NT, UK
  
• 刊物类别：Medicine
• 刊物主题：Medicine & Public Health
  Cardiology
  
• 出版者：Springer Netherlands
• ISSN：1572-8595

文摘

Purpose Six risk stratification scores have been developed to estimate mortality risk in patients receiving an implantable cardioverter-defibrillator (ICD). This study aims at validating and comparing these risk scores in patients having elective ICD generator replacement (GR) and assessing the outcome of patients submitted to this procedure.